Connor, Clark & Lunn Investment Management (CC&L)’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-160,356
| Closed | -$8.97M | – | 1365 |
|
|
2022
Q3 | $8.97M | Buy |
160,356
+131,876
| +463% | +$7.38M | 0.06% | 217 |
|
|
2022
Q2 | $1.47M | Buy |
28,480
+17,943
| +170% | +$929K | 0.01% | 533 |
|
|
2022
Q1 | $766K | Buy |
+10,537
| New | +$766K | ﹤0.01% | 712 |
|
|
2021
Q4 | – | Sell |
-61,732
| Closed | -$8.28M | – | 1164 |
|
|
2021
Q3 | $8.28M | Sell |
61,732
-4,380
| -7% | -$588K | 0.04% | 272 |
|
|
2021
Q2 | $10.7M | Buy |
66,112
+50,380
| +320% | +$8.16M | 0.05% | 239 |
|
|
2021
Q1 | $1.26M | Buy |
+15,732
| New | +$1.26M | 0.01% | 655 |
|